Literature DB >> 18524936

A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Kerry J Welsh1, April N Abbott2, Shen-An Hwang2, Jessica Indrigo3, Lisa Y Armitige4,2,1, Michael R Blackburn5,2,1, Robert L Hunter6,2,1, Jeffrey K Actor6,2,1.   

Abstract

Trehalose 6,6'-dimycolate (TDM) is a glycolipid component of the mycobacterial cell wall that causes immune responses in mice similar to Mycobacterium tuberculosis (MTB) infection, including granuloma formation with production of proinflammatory cytokines. The precise roles of tumour necrosis factor (TNF)-alpha, complement C5 and interleukin (IL)-6 in the molecular events that lead to the initiation and maintenance of the granulomatous response to TDM have not been fully elucidated. Macrophage proinflammatory responses from wild-type and complement-deficient mice after infection with MTB were assessed, and compared to responses from organisms in which surface TDM had been removed. Removal of TDM abolished proinflammatory responses, markedly so in the complement-deficient macrophages. Mice deficient in TNF-alpha, C5a and IL-6, along with wild-type C57BL/6 controls, were intravenously injected with TDM in a water-in-oil emulsion, and analysed for histological response and cytokine production in lungs. Wild-type C57BL/6 mice formed granulomas with increased production of IL-1beta, IL-6, TNF-alpha, macrophage inflammatory protein-1alpha (MIP-1alpha), IL-12p40, interferon-gamma (IFN-gamma), and IL-10 protein and mRNA. TNF-alpha-deficient mice failed to produce a histological response to TDM, with no increases in cytokine production following TDM administration. While C5a-deficient mice exhibited inflammation, they did not form structured granulomas and initially had decreased production of proinflammatory mediators. IL-6-deficient mice initiated granuloma formation, but failed to maintain the granulomas through day 7 and demonstrated decreased early production of proinflammatory mediators in comparison to wild-type mice. These data suggest that TNF-alpha is critical for initiation of the granulomatous response, C5a is necessary for formation of cohesive granulomas, and IL-6 plays a key role in the granuloma maintenance response to mycobacterial TDM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524936      PMCID: PMC2556040          DOI: 10.1099/mic.0.2008/016923-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  58 in total

Review 1.  Complement and IL-12: yin and yang.

Authors:  C L Karp; M Wills-Karp
Journal:  Microbes Infect       Date:  2001-02       Impact factor: 2.700

2.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice.

Authors:  H Yamagami; T Matsumoto; N Fujiwara; T Arakawa; K Kaneda; I Yano; K Kobayashi
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  A role for complement C5 in organism containment and granulomatous response during murine tuberculosis.

Authors:  J K Actor; E Breij; R A Wetsel; H Hoffmann; R L Hunter; C Jagannath
Journal:  Scand J Immunol       Date:  2001-05       Impact factor: 3.487

4.  Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice.

Authors:  H Kaneko; H Yamada; S Mizuno; T Udagawa; Y Kazumi; K Sekikawa; I Sugawara
Journal:  Lab Invest       Date:  1999-04       Impact factor: 5.662

5.  Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.

Authors:  I P Oswald; C M Dozois; S Fournout; J F Petit; G Lemaire
Journal:  Eur Cytokine Netw       Date:  1999-12       Impact factor: 2.737

6.  Cytokine mRNA expression and serum cortisol evaluation during murine lung inflammation induced by Mycobacterium tuberculosis.

Authors:  J K Actor; C D Leonard; V E Watson; A Wells; C Jagannath; R L Hunter; A Dasgupta
Journal:  Comb Chem High Throughput Screen       Date:  2000-08       Impact factor: 1.339

7.  NF-kappaB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells.

Authors:  M H Hsu; M Wang; D D Browning; N Mukaida; R D Ye
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

8.  Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection.

Authors:  B M Saunders; A A Frank; I M Orme; A M Cooper
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5).

Authors:  C Jagannath; H Hoffmann; E Sepulveda; J K Actor; R A Wetsel; R L Hunter
Journal:  Scand J Immunol       Date:  2000-10       Impact factor: 3.487

10.  Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6'-dimycolate.

Authors:  R L Perez; J Roman; S Roser; C Little; M Olsen; J Indrigo; R L Hunter; J K Actor
Journal:  J Interferon Cytokine Res       Date:  2000-09       Impact factor: 2.607

View more
  32 in total

1.  Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology.

Authors:  Kerry J Welsh; Shen-An Hwang; Sydney Boyd; Marian L Kruzel; Robert L Hunter; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2011-12-03       Impact factor: 3.131

2.  Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response.

Authors:  Kerry J Welsh; Shen-An Hwang; Robert L Hunter; Marian L Kruzel; Jeffrey K Actor
Journal:  Transl Res       Date:  2010-06-30       Impact factor: 7.012

3.  Self and nonself recognition through C-type lectin receptor, Mincle.

Authors:  Yasunobu Miyake; Eri Ishikawa; Tetsuaki Ishikawa; Sho Yamasaki
Journal:  Self Nonself       Date:  2010-10

4.  Mycobacterial trehalose 6,6'-dimycolate induced vascular occlusion is accompanied by subendothelial inflammation.

Authors:  Shen-An Hwang; Caitlan D Byerly; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2019-04-26       Impact factor: 3.131

5.  Histopathological features and expression profiles of cytokines, chemokines and SOCS family proteins in trehalose 6,6'-dimycolate-induced granulomatous lesions.

Authors:  Yusuke Sakai; Kazuyuki Uchida; Hiroyuki Nakayama
Journal:  Inflamm Res       Date:  2010-11-26       Impact factor: 4.575

6.  Mycobacterial Trehalose 6,6'-Dimycolate-Induced M1-Type Inflammation.

Authors:  Thao K T Nguyen; John d'Aigle; Luis Chinea; Zainab Niaz; Robert L Hunter; Shen-An Hwang; Jeffrey K Actor
Journal:  Am J Pathol       Date:  2019-11-14       Impact factor: 4.307

7.  Oral recombinant human or mouse lactoferrin reduces Mycobacterium tuberculosis TDM induced granulomatous lung pathology.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Biochem Cell Biol       Date:  2016-07-27       Impact factor: 3.626

8.  The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis.

Authors:  Léanie Kleynhans; Nelita Du Plessis; Nasiema Allie; Muazzam Jacobs; Martin Kidd; Paul D van Helden; Gerhard Walzl; Katharina Ronacher
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

Review 9.  TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis.

Authors:  Robert L Hunter; Lisa Armitige; Chinnaswamy Jagannath; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

10.  Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle.

Authors:  Eri Ishikawa; Tetsuaki Ishikawa; Yasu S Morita; Kenji Toyonaga; Hisakata Yamada; Osamu Takeuchi; Taroh Kinoshita; Shizuo Akira; Yasunobu Yoshikai; Sho Yamasaki
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.